PriceTargets.com logo

Autonomix Medical - AMIX Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $42.00
  • Forecasted Upside: 553.19%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$6.43 As of 07/2/2026 05:00 PM ET
+0 (0.00%)

This chart shows the closing price for AMIX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Autonomix Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMIX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMIX

Analyst Price Target is $42.00
▲ +553.19% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Autonomix Medical in the last 3 months. The average price target is $42.00, with a high forecast of $42.00 and a low forecast of $42.00. The average price target represents a 553.19% upside from the last price of $6.43.

This chart shows the closing price for AMIX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in Autonomix Medical. This rating has held steady since September 2025, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/10/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/10/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/9/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/7/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/5/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/5/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
6/4/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
7/4/2026

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/23/2026Weiss RatingsUpgradeSell (E) ➝ Sell (E+)
6/3/2026Weiss RatingsDowngradeSell (E+) ➝ Sell (E)
6/2/2026Zacks ResearchUpgradeHold
5/18/2026Weiss RatingsUpgradeSell (E) ➝ Sell (E+)
5/4/2026Weiss RatingsDowngradeSell (E+) ➝ Sell (E)
4/20/2026Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
2/17/2026Maxim GroupLower TargetBuy ➝ Buy$105.00 ➝ $42.00
1/21/2026Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
10/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
9/27/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
8/28/2025Zacks ResearchDowngradeStrong-Buy ➝ Hold
4/29/2025Maxim GroupInitiated CoverageBuy$105.00
9/3/2024LADENBURG THALM/SH SHInitiated CoverageBuy$588.00
(Data available from 7/4/2021 forward)

News Sentiment Rating

0.20 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
12/6/2025
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/5/2026
  • 0 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 3 very negative mentions
Mentions as of
2/4/2026
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
3/6/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/5/2026
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Mentions as of
5/5/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/4/2026
  • 0 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/4/2026

Current Sentiment

  • 0 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Autonomix Medical logo
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Read More

Today's Range

Now: $6.43
Low: $6.43
High: $6.89

50 Day Range

MA: $7.63
Low: $5.72
High: $8.78

52 Week Range

Now: $6.43
Low: $4.20
High: $55.44

Volume

9,115 shs

Average Volume

17,831 shs

Market Capitalization

$3.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Autonomix Medical?

The following equities research analysts have issued research reports on Autonomix Medical in the last twelve months: Maxim Group, Wall Street Zen, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for AMIX.

What is the current price target for Autonomix Medical?

0 Wall Street analysts have set twelve-month price targets for Autonomix Medical in the last year. Their average twelve-month price target is $42.00, suggesting a possible upside of 553.2%. Maxim Group has the highest price target set, predicting AMIX will reach $42.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $42.00 for Autonomix Medical in the next year.
View the latest price targets for AMIX.

What is the current consensus analyst rating for Autonomix Medical?

Autonomix Medical currently has 1 sell rating, 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AMIX, but not buy more shares or sell existing shares.
View the latest ratings for AMIX.

What other companies compete with Autonomix Medical?

Other companies that are similar to Autonomix Medical include Jin Medical International, Femasys, Co-Diagnostics, OSR and SurgePays. Learn More about companies similar to Autonomix Medical.

How do I contact Autonomix Medical's investor relations team?

The company's listed phone number is 713-588-6150 and its investor relations email address is [email protected]. The official website for Autonomix Medical is autonomix.com. Learn More about contacing Autonomix Medical investor relations.